Teleflex (NYSE:TFX – Get Free Report) and Innovative Eyewear (NASDAQ:LUCY – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Teleflex and Innovative Eyewear, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Teleflex | 0 | 6 | 5 | 1 | 2.58 |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
Teleflex presently has a consensus target price of $163.30, suggesting a potential upside of 4.46%. Given Teleflex’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Teleflex is more favorable than Innovative Eyewear.
Volatility & Risk
Teleflex has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.75, indicating that its share price is 175% more volatile than the S&P 500.
Insider and Institutional Ownership
95.6% of Teleflex shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 0.7% of Teleflex shares are owned by company insiders. Comparatively, 1.8% of Innovative Eyewear shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Teleflex and Innovative Eyewear”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Teleflex | $2.26 billion | 2.75 | -$905.64 million | $8.23 | 18.99 |
| Innovative Eyewear | $2.66 million | 2.76 | -$7.59 million | ($1.29) | -0.65 |
Innovative Eyewear has lower revenue, but higher earnings than Teleflex. Innovative Eyewear is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Teleflex and Innovative Eyewear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Teleflex | 13.51% | 10.57% | 4.96% |
| Innovative Eyewear | -216.76% | -102.66% | -92.20% |
Summary
Teleflex beats Innovative Eyewear on 10 of the 14 factors compared between the two stocks.
About Teleflex
Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.
About Innovative Eyewear
Innovative Eyewear, Inc. is a technology and eyewear company that develops and sells smart glasses designed to combine traditional eyewear with wireless audio and hands-free digital functionality. Its products generally incorporate speakers, microphones and Bluetooth connectivity, allowing users to listen to music, make calls and interact with voice assistants while keeping their hands free. The company markets products under the Lucyd brand, including prescription-capable eyewear, sunglasses and blue-light-filtering styles.
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
